Search

Literature Lessons

By Ted Rosen, MD, FAAD, Editor-in-Chief Off-label Pearl Patients receiving epidermal growth factor receptor inhibitors for the treatment of cancer are prone to develop severe acneiform eruptions. This adverse event may be prevented or lessened in severity by prophylactic administration of oral tetracycline derivatives at typical therapeutic doses. To read more: Yu Z, et al. […]